BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
7 results:

  • 1. Enhancing kdm5a and TLR activity improves the response to immune checkpoint blockade.
    Wang L; Gao Y; Zhang G; Li D; Wang Z; Zhang J; Hermida LC; He L; Wang Z; Si J; Geng S; Ai R; Ning F; Cheng C; Deng H; Dimitrov DS; Sun Y; Huang Y; Wang D; Hu X; Wei Z; Wang W; Liao X
    Sci Transl Med; 2020 Sep; 12(560):. PubMed ID: 32908002
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histone demethylase kdm5a inhibits glioma cells migration and invasion by down regulating ZEB1.
    Dai B; Huang H; Guan F; Zhu G; Xiao Z; Mao B; Su H; Hu Z
    Biomed Pharmacother; 2018 Mar; 99():72-80. PubMed ID: 29324315
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
    Banelli B; Daga A; Forlani A; Allemanni G; Marubbi D; Pistillo MP; Profumo A; Romani M
    Oncotarget; 2017 May; 8(21):34896-34910. PubMed ID: 28432280
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The histone demethylase kdm5a is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gamma knife surgery for brain metastasis from hepatocellular carcinoma.
    Xu Q; Wu P; Feng Y; Ye K; Tong Y; Zhou Y
    PLoS One; 2014; 9(2):e88317. PubMed ID: 24516635
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
    Lee CH; Alpert BO; Sankaranarayanan P; Alter O
    PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.